Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents-Reference-Cited by-同舟云学术

Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents

Published:2016-12-26 Issue:2 Volume:21 Page:145-157
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Rajajeyabalachandran Gurukumari¹,Kumar Swetha¹,Murugesan Thanabal¹,Ekambaram Shanthi¹,Padmavathy Ramya¹,Jegatheesan Sooriya Kumar¹,Mullangi Ramesh¹,Rajagopal Sriram¹

Affiliation:

1. Bioinformatics, Jubilant Biosys Ltd., Bangalore, India

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2017.1272580

Reference124 articles.

1. Epigenetics and human disease

2. Cancer genetics of epigenetic genes

3. Roles of histone methyl‐modifying enzymes in development and progression of cancer

4. Histone methyltransferases in cancer

5. Histone Lysine-Specific Methyltransferases and Demethylases in Carcinogenesis: New Targets for Cancer Therapy and Prevention

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into SMYD2 and SMYD3 inhibitors: from potential anti-tumoural therapy to a variety of new applications;Molecular Biology Reports;2021-09-12

2. Exploring new targets for the treatment of hepatitis-B virus and hepatitis-B virus-associated hepatocellular carcinoma;Medicine;2021-08-20

3. SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways;Cancers;2020-01-06

4. Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer;Digestive Diseases and Sciences;2019-08-22

5. Unveiling the Biochemistry of the Epigenetic Regulator SMYD3;Biochemistry;2019-08-07